Researchers used a decision tree model combining clinical effectiveness, utility and cost data. They conducted sensitivity analyses to determine the robustness of the model outcomes.
The oral probiotics strategy offered patients 0.05876 quality-adjusted life years, and the no probiotics strategy offered 0.056 quality-adjusted life years. The cost of the oral probiotics strategy was $16,668.70, while the no probiotics strategy was $20,355.28.
“The oral probiotics strategy exhibited higher QALY and lower cost, and represents the cost-saving strategy,” study authors wrote.
More articles on healthcare quality:
Staffing issues force Denver hospital to suspend transplant program: 7 things to know
Man sues South Carolina hospital for allegedly leaving surgical glove inside him after surgery
Joint Commission denies Baltimore hospital preliminary accreditation over issues with dialysis center
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
